Satoshi Minoshima, MD PhD - Publications

Affiliations: 
Radiology University of Washington, Seattle, Seattle, WA 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=139
Website:
http://www.rad.washington.edu/radiology-personnel/minoshim

131 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Thientunyakit T, Minoshima S. Temporal muscle uptake causing an unusual focal artifact on three-dimensional stereotactic surface projections statistical maps of (18F) fluorodeoxyglucose brain positron emission tomography in a patient with Alzheimer's disease. World Journal of Nuclear Medicine. 19: 168-170. PMID 32939211 DOI: 10.4103/Wjnm.Wjnm_97_18  0.342
2019 Cross DJ, Meabon JS, Cline MM, Richards TL, Stump AJ, Cross CG, Minoshima S, Banks WA, Cook DG. Paclitaxel Reduces Brain Injury from Repeated Head Trauma in Mice. Journal of Alzheimer's Disease : Jad. PMID 30664506 DOI: 10.3233/Jad-180871  0.33
2018 Anzai Y, Minoshima S, Lee VS. Enhancing Value of MRI: A Call for Action. Journal of Magnetic Resonance Imaging : Jmri. PMID 30431676 DOI: 10.1002/Jmri.26239  0.339
2018 Matesan M, Gaddikeri S, Longfellow K, Miyaoka R, Elojeimy S, Elman S, Hu SC, Minoshima S, Lewis D. I-123 DaTscan SPECT Brain Imaging in Parkinsonian Syndromes: Utility of the Putamen-to-Caudate Ratio. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29905019 DOI: 10.1111/Jon.12530  0.308
2018 Cherrier MM, Cross DJ, Higano CS, Minoshima S. Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 21: 394-402. PMID 29700388 DOI: 10.1038/S41391-018-0037-X  0.357
2017 Mallik A, Drzezga A, Minoshima S. Clinical Amyloid Imaging. Seminars in Nuclear Medicine. 47: 31-43. PMID 27987555 DOI: 10.1053/J.Semnuclmed.2016.09.005  0.379
2017 Foster NL, DuPrey R, King RD, Hoffman JM, Yap JT, Minoshima S, Horn K, Zhang Y. How Amyloid Pet Changes Cognitive Care: A Broader View Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2279  0.305
2016 Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, ... ... Minoshima S, et al. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27987029 DOI: 10.1007/S00259-016-3598-8  0.319
2016 Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Saraf LJ, Lammertsma AA, Law I, ... ... Minoshima S, et al. The need of standardization and of large clinical studies in an emerging indication of [(18)F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27924371 DOI: 10.1007/S00259-016-3589-9  0.322
2016 Matesan MC, Elojeimy S, Minoshima S. 123I-FP-CIT and 99mTc-HMPAO in Pathologically Confirmed Progressive Supranuclear Palsy. Clinical Nuclear Medicine. 41. PMID 27764040 DOI: 10.1097/Rlu.0000000000001400  0.372
2016 Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1316-22. PMID 27481605 DOI: 10.2967/Jnumed.116.174615  0.359
2016 Meabon JS, Huber BR, Cross DJ, Richards TL, Minoshima S, Pagulayan KF, Li G, Meeker KD, Kraemer BC, Petrie EC, Raskind MA, Peskind ER, Cook DG. Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction. Science Translational Medicine. 8: 321ra6. PMID 26764157 DOI: 10.1126/Scitranslmed.Aaa9585  0.308
2016 Eisenmenger LB, Huo EJ, Hoffman JM, Minoshima S, Matesan MC, Lewis DH, Lopresti BJ, Mathis CA, Okonkwo DO, Mountz JM. Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia. Seminars in Nuclear Medicine. 46: 57-87. PMID 26687858 DOI: 10.1053/J.Semnuclmed.2015.09.003  0.384
2016 Minoshima S. How Ad-Specific Is Fdg As A Biomarker? Alzheimers & Dementia. 12: 166. DOI: 10.1016/J.Jalz.2016.06.279  0.323
2015 Kakimoto A, Ito S, Okada H, Nishizawa S, Minoshima S, Ouchi Y. Age-related gender-specific changes in the brain metabolism and morphology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26609179 DOI: 10.2967/Jnumed.115.166439  0.388
2015 Weaver KE, Richards TL, Logsdon RG, McGough EL, Minoshima S, Aylward EH, Kleinhans NM, Grabowski TJ, McCurry SM, Teri L. Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment. Biomed Research International. 2015: 610605. PMID 26417597 DOI: 10.1155/2015/610605  0.347
2015 Teipel S, Drzezga A, Grothe MJ, Barthel H, Chételat G, Schuff N, Skudlarski P, Cavedo E, Frisoni GB, Hoffmann W, Thyrian JR, Fox C, Minoshima S, Sabri O, Fellgiebel A. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection. The Lancet. Neurology. 14: 1037-53. PMID 26318837 DOI: 10.1016/S1474-4422(15)00093-9  0.347
2015 Minoshima S. Establishing amyloid PET imaging biomarkers: Ongoing efforts American Journal of Neuroradiology. 36: 1245-1246. DOI: 10.3174/Ajnr.A4433  0.347
2014 Murray J, Tsui WH, Li Y, McHugh P, Williams S, Cummings M, Pirraglia E, Solnes L, Osorio R, Glodzik L, Vallabhajosula S, Drzezga A, Minoshima S, de Leon MJ, Mosconi L. FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease. Advances in Molecular Imaging. 4: 15-26. PMID 25530915 DOI: 10.4236/Ami.2014.42003  0.347
2014 Sham JG, Kievit FM, Grierson JR, Chiarelli PA, Miyaoka RS, Zhang M, Yeung RS, Minoshima S, Park JO. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 2032-7. PMID 25359880 DOI: 10.2967/Jnumed.114.145102  0.301
2014 Krull KR, Minoshima S, Edelmann M, Morris B, Sabin ND, Brinkman TM, Armstrong GT, Robison LL, Hudson MM, Shulkin B. Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1805-10. PMID 25315244 DOI: 10.2967/Jnumed.114.142950  0.321
2014 Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B, Richards TL, Mankoff DA, Minoshima S, O'Sullivan F, Eyal S, Hsiao P, Maravilla K, Unadkat JD. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1106-11. PMID 24842892 DOI: 10.2967/Jnumed.113.130161  0.343
2014 Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 34: 684-701. PMID 24819789 DOI: 10.1148/Rg.343135065  0.392
2014 Drzezga A, Barthel H, Minoshima S, Sabri O. Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 47S-55S. PMID 24819417 DOI: 10.2967/Jnumed.113.129254  0.363
2014 Petrie EC, Cross DJ, Yarnykh VL, Richards T, Martin NM, Pagulayan K, Hoff D, Hart K, Mayer C, Tarabochia M, Raskind MA, Minoshima S, Peskind ER. Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veterans. Journal of Neurotrauma. 31: 425-36. PMID 24102309 DOI: 10.1089/Neu.2013.2952  0.344
2014 Lin ZS, Avinash G, McMillan K, Yan L, Minoshima S. Longitudinal MR cortical thinning of individuals and its correlation with PET metabolic reduction: A measurement consistency and correctness studies Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9038. DOI: 10.1117/12.2043060  0.363
2014 Minoshima S. Fluorodeoxyglucose (18F) Pet Alzheimers & Dementia. 10: 239. DOI: 10.1016/J.Jalz.2014.04.356  0.307
2013 Ito K, Mori E, Fukuyama H, Ishii K, Washimi Y, Asada T, Mori S, Meguro K, Kitamura S, Hanyu H, Nakano S, Matsuda H, Kuwabara Y, Hashikawa K, Momose T, ... ... Minoshima S, et al. Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study. Annals of Nuclear Medicine. 27: 898-906. PMID 24061691 DOI: 10.1007/S12149-013-0768-7  0.336
2013 Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM. Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e106-9. PMID 23809369 DOI: 10.1016/J.Jalz.2013.06.001  0.395
2013 Cross DJ, Anzai Y, Petrie EC, Martin N, Richards TL, Maravilla KR, Peskind ER, Minoshima S. Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1278-84. PMID 23804325 DOI: 10.2967/Jnumed.112.116558  0.391
2013 Padia SA, Alessio A, Kwan SW, Lewis DH, Vaidya S, Minoshima S. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis. Journal of Vascular and Interventional Radiology : Jvir. 24: 1147-53. PMID 23792126 DOI: 10.1016/J.Jvir.2013.04.018  0.347
2013 Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM. Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1011-3. PMID 23753186 DOI: 10.2967/Jnumed.113.127068  0.402
2013 Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e-1-16. PMID 23360977 DOI: 10.1016/J.Jalz.2013.01.002  0.383
2013 Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 476-90. PMID 23359661 DOI: 10.2967/Jnumed.113.120618  0.383
2013 Lin Z, Avinash G, Mcmillan K, Yan L, Sirohey S, Minoshima S. Quantitative measurement of mr cortical atrophy: Mr brain surface intensity model (bsim) and group and individual cortical thinning studies Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8672. DOI: 10.1117/12.2006474  0.362
2013 Peskind E, Petrie E, Cross D, Li G, Mayer C, Minoshima S, Zhang J, Montine T, Raskind M. Cerebrospinal fluid biomarkers and PET imaging of cerebral glucose metabolism in Iraq and Afghanistan veterans: Converging evidence of brain dysfunction and neurodegeneration Alzheimers & Dementia. 9: 229. DOI: 10.1016/J.Jalz.2013.05.434  0.377
2012 Bohnen NI, Minoshima S. FDG-PET and molecular brain imaging in the movement disorders clinic. Neurology. 79: 1306-7. PMID 22914830 DOI: 10.1212/Wnl.0B013E31826C1Be1  0.384
2012 Zhang Y, Minoshima S, Vesselle H, Lewis DH. A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings. Clinical Nuclear Medicine. 37: e173-5. PMID 22691528 DOI: 10.1097/Rlu.0B013E31824C5F0E  0.384
2012 Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 59-71. PMID 22173840 DOI: 10.2967/Jnumed.111.096578  0.391
2012 Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology. 69: 29-38. PMID 21911655 DOI: 10.1001/Archneurol.2011.233  0.31
2012 Deo A, Borson S, Link J, Eary J, Richards T, Mankoff D, Hsiao P, Minoshima S, Maravilla K, Unadkat J. Activity of P-glycoprotein, an ABC efflux transporter at the blood-brain barrier, is compromised in Alzheimer's disease Alzheimers & Dementia. 8: 698. DOI: 10.1016/J.Jalz.2012.05.1880  0.309
2011 Kakimoto A, Kamekawa Y, Ito S, Yoshikawa E, Okada H, Nishizawa S, Minoshima S, Ouchi Y. New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method. Plos One. 6: e25033. PMID 21966405 DOI: 10.1371/Journal.Pone.0025033  0.361
2011 Toney LK, McCue TJ, Minoshima S, Lewis DH. Nuclear medicine imaging in dementia: a practical overview for hospitalists. Hospital Practice (1995). 39: 149-60. PMID 21881402 DOI: 10.3810/Hp.2011.08.590  0.399
2011 Kaneta T, Okamura N, Minoshima S, Furukawa K, Tashiro M, Furumoto S, Iwata R, Fukuda H, Takahashi S, Yanai K, Kudo Y, Arai H. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227. Annals of Nuclear Medicine. 25: 732-9. PMID 21792587 DOI: 10.1007/S12149-011-0518-7  0.396
2011 Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 848-55. PMID 21571793 DOI: 10.2967/Jnumed.111.089946  0.364
2011 Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Archives of Neurology. 68: 51-7. PMID 20837822 DOI: 10.1001/Archneurol.2010.225  0.358
2011 Peskind ER, Petrie EC, Cross DJ, Pagulayan K, McCraw K, Hoff D, Hart K, Yu CE, Raskind MA, Cook DG, Minoshima S. Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms. Neuroimage. 54: S76-82. PMID 20385245 DOI: 10.1016/J.Neuroimage.2010.04.008  0.361
2011 Anzai Y, Minoshima S. Imaging of traumatic brain injury: Current and future Imaging in Medicine. 3: 153-165. DOI: 10.2217/Iim.11.11  0.353
2011 Kaneta T, Okamura N, Minoshima S, Furukawa K, Watanuki S, Fukuda H, Iwata R, Takahashi S, Yanai K, Kudo Y, Arai H. A modified method for 3D-SSP analyses of amyloid PET imaging Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.090  0.343
2010 Mohr BC, Minoshima S. F-18 fluorodeoxyglucose PET/CT findings in a case of anti-NMDA receptor encephalitis. Clinical Nuclear Medicine. 35: 461-3. PMID 20479604 DOI: 10.1097/Rlu.0B013E3181Db4D4A  0.379
2010 Foster NL, Wang AY, Fletcher PT, Joshi S, Minoshima S, Jagust WJ, Chen K, Reiman EM, Weiner MW. Topographic extent of cerebral hypometabolism predicts time of conversion from aMCI to Alzheimer's disease: Data from the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 6: S298. DOI: 10.1016/J.Jalz.2010.05.976  0.314
2009 Hattori N, Swan M, Stobbe GA, Uomoto JM, Minoshima S, Djang D, Krishnananthan R, Lewis DH. Differential SPECT activation patterns associated with PASAT performance may indicate frontocerebellar functional dissociation in chronic mild traumatic brain injury. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1054-61. PMID 19525460 DOI: 10.2967/Jnumed.108.060368  0.336
2009 Petrie EC, Cross DJ, Galasko D, Schellenberg GD, Raskind MA, Peskind ER, Minoshima S. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Archives of Neurology. 66: 632-7. PMID 19433663 DOI: 10.1001/Archneurol.2009.59  0.372
2009 Yeatman CF, Minoshima S. F-18 fluorodeoxyglucose PET/CT findings in active hiccups. Clinical Nuclear Medicine. 34: 197-8. PMID 19352293 DOI: 10.1097/Rlu.0B013E3181966Fd9  0.348
2009 Ogura T, Hida K, Masuzuka T, Saito H, Minoshima S, Nishikawa K. An automated ROI setting method using NEUROSTAT on cerebral blood flow SPECT images. Annals of Nuclear Medicine. 23: 33-41. PMID 19205836 DOI: 10.1007/S12149-008-0203-7  0.333
2009 Ishii K, Kanda T, Uemura T, Miyamoto N, Yoshikawa T, Shimada K, Ohkawa S, Minoshima S. Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP. European Journal of Nuclear Medicine and Molecular Imaging. 36: 831-40. PMID 19148640 DOI: 10.1007/S00259-008-1051-3  0.341
2008 Flexman JA, Cross DJ, Lewellen BL, Miyoshi S, Kim Y, Minoshima S. Magnetically targeted viral envelopes: a PET investigation of initial biodistribution. Ieee Transactions On Nanobioscience. 7: 223-32. PMID 18779103 DOI: 10.1109/Tnb.2008.2002288  0.338
2008 Driver CB, Wallace DJ, Lee JC, Forbess CJ, Pourrabbani S, Minoshima S, Waxman AD, Weisman MH. Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism. 59: 332-7. PMID 18311758 DOI: 10.1002/Art.23308  0.331
2008 Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, ... ... Minoshima S, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 390-8. PMID 18287270 DOI: 10.2967/Jnumed.107.045385  0.398
2008 Petrie EC, Cross DJ, Galasko D, Li G, Raskind MA, Peskind ER, Minoshima S. P1-276: Voxel-based correlations between cerebral glucose metabolism and cerebrospinal fluid Alzheimer's disease biomarkers in normal controls Alzheimer's & Dementia. 4: T297-T298. DOI: 10.1016/J.Jalz.2008.05.866  0.317
2008 Sadeghi N, Foster NL, Wang AY, Minoshima S, Lieberman AP, Tolga T. AbstractPoster presentation: Monday posterP2-068: Automatic diagnostic classification of dementia with FDG-PET using a spatial decision tree approach Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1141  0.32
2008 Sadeghi N, Foster N, Wang A, Minoshima S, Lieberman A, Tasdizen T. IC-P1-051: Automatic diagnostic classification of dementia with FDG-PET using a spatial - decision tree approach Alzheimer's & Dementia. 4: T28-T28. DOI: 10.1016/J.Jalz.2008.05.061  0.306
2007 Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain : a Journal of Neurology. 130: 2616-35. PMID 17704526 DOI: 10.1093/Brain/Awm177  0.399
2007 Mosconi L, Tsui WH, Pupi A, De Santi S, Drzezga A, Minoshima S, de Leon MJ. (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1129-34. PMID 17574982 DOI: 10.2967/Jnumed.107.040675  0.377
2007 Hosoda K, Ishii K, Minoshima S, Kohmura E. Probabilistic cortical surface map of the middle cerebral artery territory for single-photon emission computed tomography studies. Journal of Neurosurgery. 106: 119-27. PMID 17236497 DOI: 10.3171/Jns.2007.106.1.119  0.312
2006 Uchida Y, Minoshima S, Okada S, Kawata T, Ito H. Diagnosis of dementia using perfusion SPECT imaging at the patient's initial visit to a cognitive disorder clinic. Clinical Nuclear Medicine. 31: 764-73. PMID 17117070 DOI: 10.1097/01.Rlu.0000246818.24566.54  0.323
2006 Flexman JA, Minoshima S, Kim Y, Miyoshi S, Lewellen BL, Cross DJ. A viral envelope as a vehicle for tracer, drug, and gene delivery. Ieee Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society. 25: 70-5. PMID 16898661 DOI: 10.1109/Memb.2006.1657790  0.302
2006 Ishiwata A, Sakayori O, Minoshima S, Mizumura S, Kitamura S, Katayama Y. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study. Acta Neurologica Scandinavica. 114: 91-6. PMID 16867030 DOI: 10.1111/J.1600-0404.2006.00661.X  0.391
2006 Lewis DH, Bluestone JP, Savina M, Zoller WH, Meshberg EB, Minoshima S. Imaging cerebral activity in recovery from chronic traumatic brain injury: a preliminary report. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 16: 272-7. PMID 16808830 DOI: 10.1111/J.1552-6569.2006.00034.X  0.355
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/Ana.20672  0.362
2005 Ishii K, Minoshima S. PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for. European Journal of Nuclear Medicine and Molecular Imaging. 32: 1463-5. PMID 16283181 DOI: 10.1007/S00259-005-1936-3  0.374
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, ... ... Minoshima S, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1  0.309
2005 Hosoda K, Kawaguchi T, Ishii K, Minoshima S, Kohmura E. Comparison of conventional region of interest and statistical mapping method in brain single-photon emission computed tomography for prediction of hyperperfusion after carotid endarterectomy. Neurosurgery. 57: 32-41; discussion 32. PMID 15987538 DOI: 10.1227/01.Neu.0000163088.66798.59  0.316
2005 Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, Ito H. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clinical Nuclear Medicine. 30: 170-6. PMID 15722820 DOI: 10.1097/00003072-200503000-00005  0.302
2005 Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology. 64: 102-7. PMID 15642911 DOI: 10.1212/01.Wnl.0000148478.39691.D3  0.372
2005 Grimmer T, Drzezga A, Riemenschneider M, Lautenschlager N, Minoshima S, Foerstl H, Kurz A. Prediction of progression to dementia in patients with mild cognitive impairment combining FDG-PET imaging with apolipoprotein E genotyping Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.147  0.393
2004 Cross DJ, Minoshima S, Anzai Y, Flexman JA, Keogh BP, Kim Y, Maravilla KR. Statistical mapping of functional olfactory connections of the rat brain in vivo. Neuroimage. 23: 1326-35. PMID 15589097 DOI: 10.1016/J.Neuroimage.2004.07.038  0.307
2004 Tang BN, Minoshima S, George J, Robert A, Swine C, Laloux P, Borght TV. Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow. European Journal of Nuclear Medicine and Molecular Imaging. 31: 1487-94. PMID 15232656 DOI: 10.1007/S00259-004-1597-7  0.393
2004 Moretti P, Lieberman AP, Wilde EA, Giordani BI, Kluin KJ, Koeppe RA, Minoshima S, Kuhl DE, Seltzer WK, Foster NL. Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis. Neurology. 62: 1865-8. PMID 15159497 DOI: 10.1212/01.Wnl.0000126447.91111.A1  0.336
2004 Minoshima S, Frey KA, Cross DJ, Kuhl DE. Neurochemical imaging of dementias. Seminars in Nuclear Medicine. 34: 70-82. PMID 14735460 DOI: 10.1053/J.Semnuclmed.2003.09.008  0.31
2004 Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Statistics in Medicine. 23: 315-26. PMID 14716732 DOI: 10.1002/Sim.1719  0.412
2003 Minoshima S. Imaging Alzheimer's disease: clinical applications. Neuroimaging Clinics of North America. 13: 769-80. PMID 15024960 DOI: 10.1016/S1052-5149(03)00099-6  0.419
2003 Noda A, Takamatsu H, Minoshima S, Tsukada H, Nishimura S. Determination of kinetic rate constants for 2-[18F]fluoro-2-deoxy-D-glucose and partition coefficient of water in conscious macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 23: 1441-7. PMID 14663339 DOI: 10.1097/01.Wcb.0000090623.86921.47  0.327
2003 Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. European Journal of Nuclear Medicine and Molecular Imaging. 30: 1104-13. PMID 12764551 DOI: 10.1007/S00259-003-1194-1  0.415
2003 Hosoda K, Kawaguchi T, Ishii K, Minoshima S, Shibata Y, Iwakura M, Ishiguro S, Kohmura E. Prediction of hyperperfusion after carotid endarterectomy by brain SPECT analysis with semiquantitative statistical mapping method. Stroke; a Journal of Cerebral Circulation. 34: 1187-93. PMID 12702841 DOI: 10.1161/01.Str.0000068781.31429.Be  0.333
2003 Albin RL, Cross D, Cornblath WT, Wald JA, Wernette K, Frey KA, Minoshima S. Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Annals of Neurology. 53: 528-32. PMID 12666122 DOI: 10.1002/Ana.10527  0.303
2002 Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. Journal of Geriatric Psychiatry and Neurology. 15: 200-9. PMID 12489916 DOI: 10.1177/089198870201500405  0.378
2002 Cameron OG, Minoshima S. Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humans. Psychosomatic Medicine. 64: 851-61. PMID 12461189 DOI: 10.1097/01.Psy.0000038939.33335.32  0.358
2002 Drzezga A, Grimmer T, Siebner H, Minoshima S, Schwaiger M, Kurz A. Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia. Journal of Neurology. 249: 1263-7. PMID 12242551 DOI: 10.1007/S00415-002-0832-Z  0.348
2001 Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology. 50: 358-65. PMID 11558792 DOI: 10.1002/Ana.1133  0.373
2001 Casey KL, Morrow TJ, Lorenz J, Minoshima S. Temporal and spatial dynamics of human forebrain activity during heat pain: analysis by positron emission tomography. Journal of Neurophysiology. 85: 951-9. PMID 11160525 DOI: 10.1152/Jn.2001.85.2.951  0.323
2001 Ladabaum U, Minoshima S, Hasler WL, Cross D, Chey WD, Owyang C. Gastric distention correlates with activation of multiple cortical and subcortical regions. Gastroenterology. 120: 369-76. PMID 11159877 DOI: 10.1053/Gast.2001.21201  0.311
2000 Domino EF, Minoshima S, Guthrie SK, Ohl L, Ni L, Koeppe RA, Cross DJ, Zubieta J. Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience. 101: 277-82. PMID 11074150 DOI: 10.1016/S0306-4522(00)00357-2  0.329
2000 Liberzon I, Taylor SF, Fig LM, Decker LR, Koeppe RA, Minoshima S. Limbic activation and psychophysiologic responses to aversive visual stimuli. Interaction with cognitive task. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 508-16. PMID 11027916 DOI: 10.1016/S0893-133X(00)00157-3  0.318
2000 Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, Zubieta JK. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse (New York, N.Y.). 38: 313-21. PMID 11020234 DOI: 10.1002/1098-2396(20001201)38:3<313::Aid-Syn10>3.0.Co;2-6  0.303
2000 Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Annals of Neurology. 48: 391-5. PMID 10976649 DOI: 10.1002/1531-8249(200009)48:3<391::Aid-Ana17>3.0.Co;2-H  0.354
2000 Cameron OG, Zubieta JK, Grunhaus L, Minoshima S. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosomatic Medicine. 62: 549-59. PMID 10949101 DOI: 10.1097/00006842-200007000-00014  0.324
2000 Casey KL, Svensson P, Morrow TJ, Raz J, Jone C, Minoshima S. Selective opiate modulation of nociceptive processing in the human brain. Journal of Neurophysiology. 84: 525-33. PMID 10899224 DOI: 10.1152/Jn.2000.84.1.525  0.318
2000 Ladabaum U, Minoshima S, Owyang C. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications V. Central nervous system processing of somatic and visceral sensory signals. American Journal of Physiology. Gastrointestinal and Liver Physiology. 279: G1-6. PMID 10898740 DOI: 10.1152/Ajpgi.2000.279.1.G1  0.317
2000 Foster NL, Minoshima S, Johanns J, Little R, Heumann ML, Kuhl DE, Gilman S. PET measures of benzodiazepine receptors in progressive supranuclear palsy. Neurology. 54: 1768-73. PMID 10802782 DOI: 10.1212/Wnl.54.9.1768  0.365
2000 Siebner HR, Peller M, Willoch F, Minoshima S, Boecker H, Auer C, Drzezga A, Conrad B, Bartenstein P. Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study. Neurology. 54: 956-63. PMID 10690992 DOI: 10.1212/Wnl.54.4.956  0.326
2000 Minoshima S. Metabolic and pathologic discordance in very early Alzheimer's disease Neurobiology of Aging. 21: 141. DOI: 10.1016/S0197-4580(00)82434-3  0.307
2000 Foster NL, Moura V, Giordani B, Minoshima S, Kuhl DE. Frontal hypometabolism in mild Alzheimer's disease is associated with more rapid progression of dementia Neurobiology of Aging. 21: 108. DOI: 10.1016/S0197-4580(00)82284-8  0.322
1999 Minoshima S, Cross DJ, Foster NL, Henry TR, Kuhl DE. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications. Annals of the New York Academy of Sciences. 893: 350-2. PMID 10672264 DOI: 10.1111/J.1749-6632.1999.Tb07852.X  0.321
1999 Anzai Y, Minoshima S, Wolf GT, Wahl RL. Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET. Radiology. 212: 285-90. PMID 10405755 DOI: 10.1148/Radiology.212.1.R99Jl02285  0.359
1999 Liberzon I, Taylor SF, Amdur R, Jung TD, Chamberlain KR, Minoshima S, Koeppe RA, Fig LM. Brain activation in PTSD in response to trauma-related stimuli. Biological Psychiatry. 45: 817-26. PMID 10202568 DOI: 10.1016/S0006-3223(98)00246-7  0.316
1999 Berent S, Giordani B, Foster N, Minoshima S, Lajiness-O'Neill R, Koeppe R, Kuhl DE. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. Journal of Psychiatric Research. 33: 7-16. PMID 10094234 DOI: 10.1016/S0022-3956(98)90048-6  0.387
1999 Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 52: 691-9. PMID 10078712 DOI: 10.1212/Wnl.52.4.691  0.371
1999 Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology. 52: 541-6. PMID 10025784 DOI: 10.1212/Wnl.52.3.541  0.314
1998 Senda M, Ishii K, Oda K, Sadato N, Kawashima R, Sugiura M, Kanno I, Ardekani B, Minoshima S, Tatsumi I. Influence of ANOVA design and anatomical standardization on statistical mapping for PET activation. Neuroimage. 8: 283-301. PMID 9758742 DOI: 10.1006/Nimg.1998.0370  0.317
1998 Henry TR, Buchtel HA, Koeppe RA, Pennell PB, Kluin KJ, Minoshima S. Absence of normal activation of the left anterior fusiform gyrus during naming in left temporal lobe epilepsy. Neurology. 50: 787-90. PMID 9521277 DOI: 10.1212/Wnl.50.3.787  0.307
1997 Bartenstein P, Weindl A, Spiegel S, Boecker H, Wenzel R, Ceballos-Baumann AO, Minoshima S, Conrad B. Central motor processing in Huntington's disease. A PET study. Brain : a Journal of Neurology. 120: 1553-67. PMID 9313639 DOI: 10.1093/Brain/120.9.1553  0.319
1997 Villringer K, Minoshima S, Hock C, Obrig H, Ziegler S, Dirnagl U, Schwaiger M, Villringer A. Assessment of local brain activation. A simultaneous PET and near-infrared spectroscopy study. Advances in Experimental Medicine and Biology. 413: 149-53. PMID 9238495 DOI: 10.1007/978-1-4899-0056-2_16  0.367
1997 Hock C, Villringer K, Müller-Spahn F, Wenzel R, Heekeren H, Schuh-Hofer S, Hofmann M, Minoshima S, Schwaiger M, Dirnagl U, Villringer A. Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurements. Brain Research. 755: 293-303. PMID 9175896 DOI: 10.1016/S0006-8993(97)00122-4  0.37
1997 Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 797-802. PMID 9170449  0.312
1997 Hirsch C, Bartenstein P, Minoshima S, Mösch D, Willoch F, Buch K, Schad D, Schwaiger M, Kurz A. Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: evaluation of an observer-independent analytic approach. Dementia and Geriatric Cognitive Disorders. 8: 98-104. PMID 9065322 DOI: 10.1159/000106613  0.401
1996 Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Annals of Neurology. 40: 399-410. PMID 8797529 DOI: 10.1002/Ana.410400309  0.356
1996 Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 47: 462-6. PMID 8757021 DOI: 10.1212/Wnl.47.2.462  0.393
1996 Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, Wahl RL. Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses Radiology. 200: 135-141. PMID 8657901 DOI: 10.1148/Radiology.200.1.8657901  0.369
1996 Burdette JH, Minoshima S, Vander Borght T, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology. 198: 837-43. PMID 8628880 DOI: 10.1148/Radiology.198.3.8628880  0.365
1996 Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 409-17. PMID 8621745 DOI: 10.1097/00004647-199605000-00007  0.317
1996 Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. The New England Journal of Medicine. 334: 752-758. PMID 8592548 DOI: 10.1056/Nejm199603213341202  0.401
1996 Villringer K, Hock C, Minoshima S, Wenzel R, Wolf I, Ziegler S, Kruschke C, Müller-Spahn F, Villringer A, Schwaiger M. Regional cerebral blood flow changes in patients with Alzheimer disease during performance of a Stroop task Neuroimage. 3. DOI: 10.1016/S1053-8119(96)80522-2  0.312
1996 Kurz A, Buchl K, Hirsch C, Minoshima S, Busch R, Bartenstein P. 491 Evidence for increased brain reserve in Alzheimer's patients With longer education. A SPECT study Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80493-3  0.308
1996 Hock C, Müller-Spahn F, Villringer K, Heekeren H, Schuh-Hofer S, Minoshima S, Wenzel R, Schwaiger M, Viliringer A. 365 Decreases in cerebral hemoglobin oxygenation during brain activation in patients with Alzheimer's disease monitored by means of near infrared spectroscopy (NIRS) — Correlation with simultaneous rCBF-PET measurements Neurobiology of Aging. 17: S91. DOI: 10.1016/S0197-4580(96)80367-8  0.379
1995 Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. Journal of Computer Assisted Tomography. 19: 541-7. PMID 7622680 DOI: 10.1097/00004728-199507000-00006  0.404
1995 Villringer K, Jäger H, Dichgans M, Ziegler S, Poppinger J, Herz M, Kruschke C, Minoshima S, Pfister HW, Schwaiger M. Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. Journal of Computer Assisted Tomography. 19: 532-6. PMID 7622678 DOI: 10.1097/00004728-199507000-00004  0.349
1994 Casey KL, Minoshima S, Berger KL, Koeppe RA, Morrow TJ, Frey KA. Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. Journal of Neurophysiology. 71: 802-7. PMID 8176441 DOI: 10.1152/Jn.1994.71.2.802  0.333
1994 Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet. 344: 895. PMID 7916431 DOI: 10.1016/S0140-6736(94)92871-1  0.305
1994 Cameron OG, Zubieta JK, Minoshima S, Koeppe R. Effects of yohimbine on cerebral blood flow in humans: a pet study Biological Psychiatry. 35: 646-647. DOI: 10.1016/0006-3223(94)90773-0  0.317
1993 Taylor S, Kornblum S, Minoshima S, Oliver L, Koeppe R, Agranoff B. Cerebral blood flow activation of the anterior cingulate gyrus studied with positron emission tomography Schizophrenia Research. 9: 210. DOI: 10.1016/0920-9964(93)90452-O  0.329
Show low-probability matches.